These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7889868)

  • 1. International Symposium on the Health Effects of Boron and its Compounds. Proceedings. Irvine, California, September 16-17, 1992.
    Environ Health Perspect; 1994 Nov; 102 Suppl 7(Suppl 7):1-141. PubMed ID: 7889868
    [No Abstract]   [Full Text] [Related]  

  • 2. Boron and its compounds: current biological research activities.
    Bolt HM; Duydu Y; Başaran N; Golka K
    Arch Toxicol; 2017 Aug; 91(8):2719-2722. PubMed ID: 28601966
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings of the 2nd International Symposium on the Health Effects of Boron and its Compounds. Irvine, California, USA. October 22-24, 1997.
    Biol Trace Elem Res; 1998; 66(1-3):1-473. PubMed ID: 10232888
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicology and health impact of environmental exposure to boron. A review.
    Minoia C; Gregotti C; Di Nucci A; Candura SM; Tonini M; Manzo L
    G Ital Med Lav; 1987; 9(3-4):119-24. PubMed ID: 3334376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The toxicokinetics of low-solubility substances (exemplified by 2 boron compounds)].
    Katsnel'son BA; Konstantinova LI; Konysheva LK; Loboda NN
    Gig Tr Prof Zabol; 1992; (5):39-42. PubMed ID: 1427354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of boron and boronated compounds.
    Benderdour M; Bui-Van T; Dicko A; Belleville F
    J Trace Elem Med Biol; 1998 Mar; 12(1):2-7. PubMed ID: 9638606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
    Ghosh P; Bag SP; Sur B; Sur P
    Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Boron compounds; past, present and future].
    Proosdij-Hartzema EG VA
    Ned Tijdschr Geneeskd; 1966 Dec; 110(51):2260-9. PubMed ID: 5341893
    [No Abstract]   [Full Text] [Related]  

  • 9. Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.
    Li X; Wang X; Zhang J; Hanagata N; Wang X; Weng Q; Ito A; Bando Y; Golberg D
    Nat Commun; 2017 Jan; 8():13936. PubMed ID: 28059072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of decaborane on blood pressure of rats. SAM-TR-67-74.
    Foster LL; Britz WE
    Tech Rep SAM-TR; 1967 Jul; ():1-8. PubMed ID: 5301215
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.
    Roda E; Nion S; Bernocchi G; Coccini T
    Brain Res; 2014 Oct; 1583():34-44. PubMed ID: 25128598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron nitride nanomaterials: biocompatibility and bio-applications.
    Merlo A; Mokkapati VRSS; Pandit S; Mijakovic I
    Biomater Sci; 2018 Aug; 6(9):2298-2311. PubMed ID: 30059084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tavaborole, a Novel Boron-Containing Small Molecule Pharmaceutical Agent for Topical Treatment of Onychomycosis: II. Prenatal and Postnatal Developmental Toxicity and Maternal Function Study.
    Ciaravino V; Coronado D; Lanphear C; Hoberman A; Chanda S
    Int J Toxicol; 2016 Sep; 35(5):543-57. PubMed ID: 27138050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tavaborole, a Novel Boron-Containing Small Molecule Pharmaceutical Agent for Topical Treatment of Onychomycosis: I. Reproductive and Developmental Toxicity Studies.
    Ciaravino V; Coronado D; Lanphear C; Hoberman A; Chanda S
    Int J Toxicol; 2016 Sep; 35(5):530-42. PubMed ID: 27044640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current data regarding the structure-toxicity relationship of boron-containing compounds.
    Farfán-García ED; Castillo-Mendieta NT; Ciprés-Flores FJ; Padilla-Martínez II; Trujillo-Ferrara JG; Soriano-Ursúa MA
    Toxicol Lett; 2016 Sep; 258():115-125. PubMed ID: 27329537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity tests of decaborane for laboratory animals. III. Chronic inhalation studies.
    ROBERTS JC; SVIRBELY JL
    AMA Arch Ind Health; 1956 Aug; 14(2):163-8. PubMed ID: 13354003
    [No Abstract]   [Full Text] [Related]  

  • 17. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
    Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA
    Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects assessment: boron compounds in the aquatic environment.
    Schoderboeck L; Mühlegger S; Losert A; Gausterer C; Hornek R
    Chemosphere; 2011 Jan; 82(3):483-7. PubMed ID: 21055789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Boron Supplementation on Expression of Hsp70 in the Spleen of African Ostrich.
    Haseeb K; Wang J; Xiao K; Yang KL; Sun PP; Wu XT; Luo Y; Song H; Liu HZ; Zhong JM; Peng KM
    Biol Trace Elem Res; 2018 Apr; 182(2):317-327. PubMed ID: 28730576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of boron derivatives on extracellular matrix formation.
    Benderdour M; Van Bui T; Hess K; Dicko A; Belleville F; Dousset B
    J Trace Elem Med Biol; 2000 Oct; 14(3):168-73. PubMed ID: 11130854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.